Post by
Noteable on Oct 31, 2023 9:20pm
AWARE-1 data analyzed showing Pelareorep priming of TME
To understand the complex tumor microenvironment (TME) and immune responses in patients before and after treatment, we used imaging mass cytometry (IMC) to perform single cell, highly multiplexed, analysis of their tissue samples.
In accordance with the prior AWARE-1 results, IMC demonstrated an enhanced immune state of the tumors after treatment.
Results confirm previous data from the window of opportunity AWARE-1 study demonstrating synergy between pelareorep in combination with atezolizumab, and a favorable immunologic response in tumors from early breast cancer (eBC) patients.
https://jitc.bmj.com/content/11/Suppl_1/662
Comment by
Noteable on Oct 31, 2023 9:26pm
November 2023 - Volume 11 - Suppl 1 SITC 38th Annual Meeting (SITC 2023) Abstracts https://jitc.bmj.com/content/11/Suppl_1 https://jitc.bmj.com/search/Pelareorep%252B%20jcode%3Ajitc